News
The committee also pointed out studies published in other parts of the world also failed to find any causal link between the ...
A doctor has warned that a new strain of Covid-19 could be immune from the vaccine. The Stratus strain has spread across the ...
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
Intense throat pain is a key symptom of COVID-19 variant NB.1.8.1, referred to as "razor blade throat." Here's what to know.
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...
NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent ...
A nasal COVID-19 vaccine developed by US biotech CyanVac has produced encouraging results in an early trial, showing potential to offer broader immunity and easier delivery than current injections.
Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...
Using a multicentric matched case-control model, the researchers included 729 cases and 2,916 controls from 47 tertiary care ...
The hearings for the second phase of the Covid Inquiry starts today. These hearings will be held in Auckland and will be ...
Karnataka Health Minister Dinesh Gundu Rao on Monday said Chief Minister Siddaramaiah’s statement linking Covid vaccine with the spate of heart attacks was not with any malafide intention. The CM had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results